Revenue: The sum of all revenue fields included for a company's operating activities.
Verona Pharma PLC American Depositary Share (VRNA) had Revenue of $76.26M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$76.26M |
$-16.32M |
|
$3.41M |
|
$72.85M |
|
$86.57M |
|
$-10.32M |
|
$-6.24M |
|
$-16.56M |
|
$-16.56M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-10.32M |
|
$-9.37M |
|
84.93M |
|
84.93M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$501.02M |
|
$1.05M |
|
$24.91M |
|
$525.94M |
|
$56.54M |
|
$241.74M |
|
$242.80M |
|
$299.34M |
|
$226.59M |
|
$226.05M |
|
$226.59M |
|
85.13M |
|
| Cash Flow Statement Financials | |
$-11.56M |
|
$-0.54M |
|
$13.46M |
|
$399.76M |
|
$401.42M |
|
$1.66M |
|
$37.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.86 |
|
-- |
|
-- |
|
0.52 |
|
1.07 |
|
95.53% |
|
-13.53% |
|
-13.53% |
|
-- |
|
-21.71% |
|
-21.40% |
|
$-12.10M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.47 |
|
1.12 |
|
80.37 |
|
-7.20% |
|
-7.22% |
|
-3.10% |
|
-3.48% |
|
$2.66 |
|
$-0.14 |
|
$-0.14 |
|